CD4 and hepatocellular carcinoma: Risk of attrition from HIV care after initiation of HAART decreased at higher baseline CD4 count (AHR: 0.832; 95% CI: 0.70–0.97; P = 0.022) and was related to the HCC of origin such that patients attending HCC2 had a significant higher risk of attrition than those attending HCC1 (AHR: 1.75; 95% CI: 1.13–2.71; P = 0.013) (Table 1).